Insider holders · CIK 0001267813
MARINUS PHARMACEUTICALS INC · MRNS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC10% Owner | — | 3,977,453 | 3,977,453 | Dec 19, 2017 · 8:30 pm EST | Form 4 |
| Bain Capital Life Sciences Partners, LP10% Owner | — | 3,977,453 | 3,977,453 | Dec 19, 2017 · 8:30 pm EST | Form 4 |
| Jeffrey Lawrence Schwartz10% Owner | — | 3,977,453 | 3,977,453 | Dec 19, 2017 · 8:30 pm EST | Form 4 |
| BCIP Life Sciences Associates, LP10% Owner | — | 3,977,453 | 3,977,453 | Dec 19, 2017 · 8:30 pm EST | Form 4 |
| Bain Capital Life Sciences Fund, L.P.10% Owner | — | 3,977,453 | 3,977,453 | Dec 19, 2017 · 8:30 pm EST | Form 4 |
| Adam Koppel10% Owner | — | 3,977,453 | 3,977,453 | Dec 19, 2017 · 8:30 pm EST | Form 4 |
| Stephen M BlochDirector | 39,550 | 2,461,398 | 2,500,948 | Feb 4, 2016 · 6:48 pm EST | Form 4/A |
| Canaan Partners VII LLC10% Owner | — | 1,850,783 | 1,850,783 | Aug 9, 2016 · 10:03 am EDT | Form 4 |
| Canaan VII LP10% Owner | — | 1,850,783 | 1,850,783 | Aug 9, 2016 · 10:03 am EDT | Form 4 |
| Christopher Michael CashmanCEO | 239,761 | — | 239,761 | Jan 30, 2019 · 4:09 pm EST | Form 4 |
| Timothy M MaylebenDirector | 50,350 | — | 50,350 | Jan 29, 2018 · 8:03 pm EST | Form 4/A |
| Edward F SmithCFO | 44,308 | — | 44,308 | Jan 30, 2019 · 4:08 pm EST | Form 4 |
| Nimesh Shah10% Owner | — | 42,550 | 42,550 | Dec 18, 2015 · 2:41 pm EST | Form 3 |
| Nicole VitulloDirector | 3,900 | 17,000 | 20,900 | Jan 24, 2018 · 4:09 pm EST | Form 4 |
| Anand Mehra10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Sofinnova Venture Partners VI GmbH & Co. KG10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Sofinnova Management VI, L.L.C.10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Eric Buatois10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Sofinnova Venture Affiliates VI LP10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Alain Azan10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| James Healy10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| SOFINNOVA VENTURE PARTNERS VI L P10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Michael Powell10% Owner | — | 15,470 | 15,470 | Oct 24, 2016 · 4:49 pm EDT | Form 4 |
| Michael R DoughertyDirector | 9,000 | — | 9,000 | Feb 1, 2017 · 4:49 pm EST | Form 3 |
| Seth H. Z. FischerDirector | 6,600 | — | 6,600 | Sep 7, 2016 · 4:07 pm EDT | Form 3 |
| Enrique J. CarrazanaDirector | 3,300 | — | 3,300 | Jan 29, 2018 · 8:02 pm EST | Form 4/A |
| Gail M FarfelChief Clinical Dev & Reg Offic | 0 | — | 0 | Apr 23, 2015 · 4:48 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.